US health experts: Vaccines will increase in the spring

Although more infectious diseases are spreading in the United States, top health officials on Sunday issued notices in the hope that both vaccine supplies and vaccination rates will continue to rise.

NBC’s “Meet the Press.” “Demand is now clearly ahead of supply,” said Dr. Anthony S. Fauci, the country’s largest infectious disease doctor.

“I can tell you that from February to March, from April, things are going to get better, because the number of vaccine doses that will be available will increase significantly.”

The number of shots fired daily in the United States has increased recently. The Centers for Disease Control and Prevention reported that more than 2.2 million doses were given on Saturday and more than 1.6 million on Friday. That brings the daily average to 1.4 million, a new target of 1.5 million shots a day in President Biden’s day.

In addition, the supply of vaccines – although still in low demand. Federal officials recently increased state shipments to 10.5 million doses a week, as Modern and Pfizer are slowly increasing production. The two companies have agreed to jointly supply 400 million doses by summer, 400 million doses – enough to vaccinate 200 million people.

Pfizer recently said it would deliver its food by May, two months ahead of schedule, in part because it is now counting the extra food in each bottle in its preparation. And Moderna is considering a product change that would increase the number of foods in its vials from 10 to 15.

Authorities are also counting on the Food and Drug Administration to allow Johnson and Johnson a food vaccine later this month. Although the company will initially supply only a few million doses to the United States, its production is expected to increase significantly by April. Novavax and other AstraZeneca vaccines may also be authorized for US use in the spring, further increasing supply.

Officials are scrambling to get more people vaccinated to identify the most contagious strains of the virus, the first to be identified in the UK and South Africa. According to a new study, various forms from the UK, known as B.1.1.7, are spreading rapidly in the United States, almost doubling in popularity every 10 days. The CDC said it could reach the dominant form of the virus in the United States by March.

Although this variety is worrisome because it is more transmissible than earlier variants, vaccine makers are more concerned about the variety discovered in South Africa, called B.1.351, as it seems. This makes the existing vaccine less effective. Numerous manufacturers have said they are working on newer versions of their vaccine, which could serve as booster shots. The Food and Drug Administration says it is working on a plan to allow these new versions of the vaccine.

Vaccine developers at AstraZeneca and the University of Oxford said Sunday they expect a modified version of their vaccine to be available by the fall.

On the CBS program “The Nation of the Nation,” Dr. Scott Gottlieb, a former FDA commissioner and a member of Pfizer’s board, said Sunday that he believes it would be possible to develop a booster that ” Things are getting better. That’s what we’re seeing. “

“I think there is a good chance that we can stay ahead of the virus,” he said.

Leave a Reply

Your email address will not be published. Required fields are marked *